[Hepatitis A, B, and C in an occupational center for the mentally handicapped]. 1998

A Arnedo, and M D Latorre, and M R Pac, and L Safont, and F Guillén, and I Aguinaga
Sección de Epidemiología, Centro de Salud Pública, Castellón.

BACKGROUND Estimation of prevalence of serologic markers of viral hepatitis A, B and C in students and staff of an occupational centre in Castellón (Spain). METHODS Serologic markers of hepatitis A (IgG anti-HAV) and B (HBsAg, anti-HBe, anti-HBc, anti-HBs) were detected by radioimmunoassay (RIA) and serologic markers of hepatitis C (anti-HCV) by immunoradiometric assay (IRMA). Ninety per cent of students (54/60) and 80% of staff (8/10) participated. RESULTS The prevalence of IgG anti-HVA was 55.6% in students and 75% in staff, increasing with age. Considering persons not vaccinated against hepatitis B, the prevalence of serologic markers hepatitis B was 18.5% in students, two HBsAg and anti-HBe positive, and nobody in staff. Serologic markers hepatitis B was associated with duration of stay institutions for mentally handicapped. None of the center was positive for anti-HCV. CONCLUSIONS Viral hepatitis prevalences present notable differences. To maintain a serological surveillance of these diseases is important to control and prevention.

UI MeSH Term Description Entries
D008297 Male Males
D008607 Intellectual Disability Subnormal intellectual functioning which originates during the developmental period. This has multiple potential etiologies, including genetic defects and perinatal insults. Intelligence quotient (IQ) scores are commonly used to determine whether an individual has an intellectual disability. IQ scores between 70 and 79 are in the borderline range. Scores below 67 are in the disabled range. (from Joynt, Clinical Neurology, 1992, Ch55, p28) Disability, Intellectual,Idiocy,Mental Retardation,Retardation, Mental,Deficiency, Mental,Intellectual Development Disorder,Mental Deficiency,Mental Retardation, Psychosocial,Deficiencies, Mental,Development Disorder, Intellectual,Development Disorders, Intellectual,Disabilities, Intellectual,Disorder, Intellectual Development,Disorders, Intellectual Development,Intellectual Development Disorders,Intellectual Disabilities,Mental Deficiencies,Mental Retardations, Psychosocial,Psychosocial Mental Retardation,Psychosocial Mental Retardations,Retardation, Psychosocial Mental,Retardations, Psychosocial Mental
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009784 Occupational Diseases Diseases caused by factors involved in one's employment. Diseases, Occupational,Occupational Illnesses,Disease, Occupational,Illnesse, Occupational,Illnesses, Occupational,Occupational Disease,Occupational Illnesse
D005260 Female Females
D006282 Health Personnel Men and women working in the provision of health services, whether as individual practitioners or employees of health institutions and programs, whether or not professionally trained, and whether or not subject to public regulation. (From A Discursive Dictionary of Health Care, 1976) Health Care Professionals,Health Care Providers,Healthcare Providers,Healthcare Workers,Health Care Professional,Health Care Provider,Healthcare Provider,Healthcare Worker,Personnel, Health,Professional, Health Care,Provider, Health Care,Provider, Healthcare
D006506 Hepatitis A INFLAMMATION of the LIVER in humans caused by a member of the HEPATOVIRUS genus, HUMAN HEPATITIS A VIRUS. It can be transmitted through fecal contamination of food or water. Hepatitis, Infectious,Infectious Hepatitis,Hepatitides, Infectious,Infectious Hepatitides
D006508 Hepatitis Antibodies Immunoglobulins raised by any form of viral hepatitis; some of these antibodies are used to diagnose the specific kind of hepatitis. Antibodies, Hepatitis
D006509 Hepatitis B INFLAMMATION of the LIVER in humans caused by a member of the ORTHOHEPADNAVIRUS genus, HEPATITIS B VIRUS. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact. Hepatitis B Virus Infection
D006510 Hepatitis B Antibodies Antibodies to the HEPATITIS B ANTIGENS, including antibodies to the surface (Australia) and core of the Dane particle and those to the "e" antigens. Anti-Australia Antigens,Anti-HBAg,Anti-Hepatitis B Antigens,Anti HBAg,Hepatitis B Virus Antibodies,Anti Australia Antigens,Anti Hepatitis B Antigens,Antibodies, Hepatitis B,Antigens, Anti-Australia,Antigens, Anti-Hepatitis B,B Antibodies, Hepatitis,B Antigens, Anti-Hepatitis,HBAg, Anti

Related Publications

A Arnedo, and M D Latorre, and M R Pac, and L Safont, and F Guillén, and I Aguinaga
January 1993, Infection,
A Arnedo, and M D Latorre, and M R Pac, and L Safont, and F Guillén, and I Aguinaga
February 1994, Epidemiology and infection,
A Arnedo, and M D Latorre, and M R Pac, and L Safont, and F Guillén, and I Aguinaga
January 1984, The Journal of infection,
A Arnedo, and M D Latorre, and M R Pac, and L Safont, and F Guillén, and I Aguinaga
May 1988, Public health,
A Arnedo, and M D Latorre, and M R Pac, and L Safont, and F Guillén, and I Aguinaga
January 1996, Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany)),
A Arnedo, and M D Latorre, and M R Pac, and L Safont, and F Guillén, and I Aguinaga
January 1995, Gastroenterologie clinique et biologique,
A Arnedo, and M D Latorre, and M R Pac, and L Safont, and F Guillén, and I Aguinaga
July 1996, Journal of the Royal Society of Medicine,
A Arnedo, and M D Latorre, and M R Pac, and L Safont, and F Guillén, and I Aguinaga
July 1990, Fortschritte der Medizin,
A Arnedo, and M D Latorre, and M R Pac, and L Safont, and F Guillén, and I Aguinaga
December 1987, Irish medical journal,
A Arnedo, and M D Latorre, and M R Pac, and L Safont, and F Guillén, and I Aguinaga
December 1993, Journal of intellectual disability research : JIDR,
Copied contents to your clipboard!